| Literature DB >> 33866323 |
David J Sturgess1, Shannon Morrison1, Brian Haluska2, Glenda C Gobe2,3, Mark A Jones4, Sonia Volante1, Bala Venkatesh2.
Abstract
BACKGROUND Sepsis is a serious clinical problem that results from the systemic response of the body to infection. Left ventricular (LV) diastolic dysfunction is increasingly appreciated as a contributor to morbidity and mortality in sepsis. Animal models may offer a method of studying diastolic dysfunction while controlling for many potential clinical confounders, such as sepsis duration, premorbid condition, and therapeutic interventions. This study sought to evaluate an endotoxemia (LPS) rodent model of sepsis, with regard to echocardiographic evidence, including tissue Doppler, of LV diastolic dysfunction and histopathology findings. MATERIAL AND METHODS Fourteen male Sprague-Dawley rats were randomly allocated (1: 1) to LPS or saline (control). Mean arterial blood pressure (MAP) was measured through cannulation of the carotid artery. After a 30-min stabilization, baseline assessment with echocardiography and blood collection was performed. Rats were administered 0.9% saline or LPS (10 mg/mL). Follow-up echocardiography and blood collection were performed after 2 h. Hearts were removed post-mortem and pathology studied using histology and immunohistochemistry. RESULTS LPS was associated with hypotension (MAP 81.86±31.67 mmHg; 124.29±20.16; p=0.02) and LV impaired relaxation (myocardial early diastolic velocity [e'] 0.06±0.02 m/s; 0.09±0.02; P=0.008). Histopathology and immunohistochemistry demonstrated evidence of interstitial myocarditis (hydropic changes and inflammation). CONCLUSIONS LPS was associated with both diastolic dysfunction (impaired relaxation) and interstitial myocarditis. These features may offer a link between the structural and functional changes that have previously been described separately in clinical sepsis. This may facilitate further studies focused upon the mechanism and potential benefit treatment of sepsis-associated cardiac dysfunction.Entities:
Mesh:
Year: 2021 PMID: 33866323 PMCID: PMC8061308 DOI: 10.12659/MSM.929512
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Final assessment of function: LPS model.
| Variable | Control | Endotoxin | P-value |
|---|---|---|---|
| MAP (mmHg) | 124.29±20.16 | 81.86±31.67 | 0.020 |
| Heart rate (bpm) | 421.1±47 | 451.2±46.4 | 0.20 |
| LVIDs (mm) | 0.39±0.12 | 0.61±0.19 | 0.13 |
| LVIDd (mm) | 0.67±0.11 | 0.26±0.14 | 0.70 |
| FS (%) | 43.3±9.5 | 58.8±17.2 | 0.085 |
| VTI (cm) | 9±6 | 5.27±1.73 | 0.093 |
| Vpeak (m/s) | 4.17±0.74 | 1.35±1.73 | 0.17 |
| E (m/s) | 0.83±0.24 | 0.79±0.13 | 0.65 |
| e′ (m/s) | 0.09±0.02 | 0.06±0.02 | 0.008 |
| E/e′ | 8.91±1.51 | 11.54±3.17 | 0.19 |
Analysis of covariance (ANCOVA) performed to compare groups at final time point with adjustment for baseline measurements. LV end-systolic (LVIDs) and end-diastolic (LVIDd) internal dimension; FS – fractional shortening; VTI – velocity time integral; Vpeak – outflow peak velocity; Peak early (E) diastolic transmitral velocity; Peak early (e′) diastolic septal mitral annulus velocity; E/e′ – ratio of E to e′.
Histopathology results for LPS model LV myocardium with HE staining.
| Group | Marked hydropic change | Mild hydropic change | Moderate hydropic change | Total |
|---|---|---|---|---|
| Control (no.) | 0 | 4 | 3 | 7 |
| (%) | 0.00 | 57.14 | 42.86 | |
| Endotoxin (no.) | 5 | 0 | 2 | 7 |
| (%) | 71.43 | 0.00 | 28.57 | |
| Total | 5 | 4 | 5 | 14 |
Marked hydropic change was observed in five out of seven endotoxic animals, but was not present in any control animals, (P=0.015; Fisher exact). HE – hematoxylin and eosin staining.
Figure 1Heart histopathology and immunohistochemistry (IHC). Panels on left are examples of control hearts and on right are LPS treatments. A and B are hematoxylin and eosin stains showing clear hydropic change in the cells of the LPS treatment. C and D contrast ED1 IHC (monocyte/macrophage) with examples of labeled cells arrowed in D. E and F contrast activated caspase-3 IHC (apoptotic cells) with examples arrowed in F and negligible labeling in E.
Immunohistochemistry for monocyte/macrophage ED1 antibody in LPS model.
| Group | No. ED1+ macrophages/monocytes | ||||
|---|---|---|---|---|---|
| <5 | 5–25 | 25–50 | 50–75 | Total | |
| Control (no.) | 4 | 2 | 1 | 0 | 7 |
| (%) | 57.14 | 28.57 | 14.29 | 0.00 | |
| Endotoxin (no.) | 0 | 2 | 3 | 2 | 7 |
| (%) | 0.00 | 28.57 | 42.86 | 28.57 | |
| Total | 4 | 4 | 4 | 2 | 14 |
Staining for macrophages (ED1) demonstrated increased numbers in the ventricular myocardium of the study group. Five out of 7 endotoxic animals, and no control animals, demonstrated >25 macrophages in at least two out of ten high powered fields (P=0.0095; Cochrane-Armitage test).